Pulse Biosciences (PLSE) Equity Ratio (2015 - 2025)

Pulse Biosciences has reported Equity Ratio for 11 years, with the latest figure at 0.85 in Q4 2025.

• For the quarter ending Q4 2025, Equity Ratio fell 1.61% year-over-year to 0.85; the trailing twelve-month figure through Dec 2025 stood at 0.85 (down 1.61% YoY), and the FY2025 full-year result was 0.85, down 1.61% from the prior year.
• Equity Ratio for Q4 2025 stood at 0.85, roughly flat from 0.85 in the prior quarter.
• The five-year high for Equity Ratio was 0.89 in Q1 2025, with the low at 0.15 in Q1 2023.
• Average Equity Ratio over 5 years is 0.62, with a median of 0.75 recorded in 2021.
• Peak annual rise in Equity Ratio reached 2697.89% in 2023, while the deepest fall reached 128.88% in 2023.
• Tracing PLSE's Equity Ratio over 5 years: stood at 0.75 in 2021, then sank by 103.85% to 0.03 in 2022, then jumped by 2697.89% to 0.75 in 2023, then advanced by 15.63% to 0.87 in 2024, then fell by 1.61% to 0.85 in 2025.
• The last three Equity Ratio figures came in at 0.85 (Q4 2025), 0.85 (Q3 2025), and 0.87 (Q2 2025), per Business Quant data.

Peer Comparison